Lansforsakringar Fondforvaltning Ab (Publ) Biomarin Pharmaceutical Inc Transaction History
Lansforsakringar Fondforvaltning Ab (Publ)
- $15.9 Billion
- Q1 2025
A detailed history of Lansforsakringar Fondforvaltning Ab (Publ) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Lansforsakringar Fondforvaltning Ab (Publ) holds 63,066 shares of BMRN stock, worth $3.47 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
63,066
Previous 66,436
5.07%
Holding current value
$3.47 Million
Previous $4.37 Million
2.11%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding BMRN
# of Institutions
668Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.25 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.05 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$978 Million1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$823 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$594 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...